SCHEMBL5848458

SCHEMBL5848458

CCCNCC(O)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.46
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ADRB2 P07550 1/20 0.44
GAA P10253 1/20 0.43
ADRB1 P08588 1/20 0.43
ADRB3 P13945 1/20 0.43
ALDH1A1 P00352 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTR1A P08908 1/20 0.42
THPO P40225 1/20 0.42
BLM P54132 1/20 0.42
NMUR2 Q9GZQ4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
CYP2C9 P11712 1/20 0.42
HIF1A Q16665 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
ABCB1 P08183 2/20 0.41
LMNA P02545 1/20 0.41
SLC6A2 P23975 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19352867 0.90 SMN1; SMN2 (0.50) AOC3KDM4EL3MBTL1ADRB2GAA
SCHEMBL2292474 0.85 HIF1A (0.53) AOC3KDM4EL3MBTL1ADRB2GAA
SCHEMBL2294187 0.85 HIF1A (0.53) AOC3KDM4EL3MBTL1ADRB2GAA
SCHEMBL3273405 0.84 ADRB2 (0.48) AOC3KDM4EL3MBTL1ADRB2GAA
SCHEMBL6458210 0.84 HIF1A (0.61) KDM4EL3MBTL1ADRB2ADRB1ALDH1A1
SCHEMBL5847939 0.84 ALDH1A1 (0.47) KDM4EL3MBTL1ADRB2ADRB1ALDH1A1
Benzene SCHEMBL27711286 0.82 KDM4E (0.55) AOC3KDM4EL3MBTL1ALDH1A1SMN1; SMN2
Benzene SCHEMBL27731714 0.82 KDM4E (0.55) AOC3KDM4EL3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL11742820 0.82 AOC3 (0.46) AOC3KDM4EL3MBTL1ADRB2GAA
SCHEMBL5847906 0.82 AOC3 (0.46) AOC3KDM4EL3MBTL1ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7112605-B2 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof Research Institute of Materia Medica Chinese Acadamy of Medical Sciences (CN) 2006-09-26 US disclosed
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof RESEARCH INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES; 2004-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040029951-A1 Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof PTGS1, PTGS2, PTGER1 AOC3 2464/4885KDM4E 1122/4885L3MBTL1 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.